Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Medicine, Multiple sclerosis, Neuromyelitis optica, Internal medicine, Rituximab, and Expanded Disability Status Scale.
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis
Brain atrophy patterns in anti-IgLON5 disease
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
Longitudinal Retinal Changes in <scp>MOGAD</scp>
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference
Comparison of Simoa<sup>TM</sup> and Ella<sup>TM</sup> to assess serum neurofilament‐light chain in multiple sclerosis
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Evaluation of efficacy and tolerability of first-line therapies in NMOSD
MRI characteristics of MOG-Ab associated disease in adults: An update
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Aquaporin-4 antibody–negative neuromyelitis optica